Expression of P450 and nuclear receptors in normal and end-stage Chinese livers

被引:57
作者
Chen, Hong [1 ]
Shen, Zhong-Yang [1 ]
Xu, Wang [1 ]
Fan, Tie-Yan [1 ]
Li, Jun [1 ]
Lu, Yuan-Fu [2 ]
Cheng, Ming-Liang [3 ]
Liu, Jie [2 ]
机构
[1] Chinese Peoples Armed Police Forces, Gen Hosp, Inst Organ Transplantat, Beijing 100039, Peoples R China
[2] Zunyi Med Coll, Kay Lab Basic Pharmacol, Minist Educ, Zunyi 563003, Guizhou Provinc, Peoples R China
[3] Guiyang Med Coll Hosp, Dept Infect Dis, Guiyang 550004, Guizhou Provinc, Peoples R China
关键词
Cytochrome P450; Nuclear receptors; mRNA expression; End-stage livers; Chinese donor livers; Hepatocellular carcinoma; GENETIC-POLYMORPHISM; HEPATIC EXPRESSION; CYTOCHROME-P450; METABOLISM; CIRRHOSIS; ASSOCIATION; PXR; TRANSPORTERS; VARIABILITY; DECREASES;
D O I
10.3748/wjg.v20.i26.8681
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the expression of P450 enzyme genes by using end-stage liver disease samples and trimmed normal Chinese donor livers. METHODS: The end-stage liver disease samples [n = 93, including hepatocellular carcinoma (HCC), peri-HCC tissue, hepatitis B virus cirrhosis, alcoholic cirrhosis, and severe cirrhosis] and trimmed normal Chinese donor livers (n = 35) from The Institute of Organ Transplantation in Beijing, China. Total RNA was extracted, purified, and subjected to real-time RT-PCR analysis. RESULTS: For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decreased 90% in HCC, 80% in alcoholic cirrhosis, and 65% in severe cirrhosis. For CYP2 family, the expression of CAR was decreased 50% in HCC, but increased 50% in peri-HCC tissues. Similar decreases (about 50%) of CYP2B6, CYP2C9, CYP2C19, CYP2D6 and CYP2E1 were observed in HCC, as compared to peri-HCC tissues and normal livers. CYP2C19 were decreased in all end-stage liver diseases and CYP2E1 also decreased in alcoholic cirrhosis and severe cirrhosis. For CYP3 family, the expression of PXR was decreased 60% in HCC, together with decreases in CYP3A4, CYP3A5, and CYP3A7. In contrast, the expression of CYP3A7 was slightly increased in HBV cirrhosis. The expression of CYP4A11 was decreased 85% in HCC, 7% in alcoholic cirrhosis and severe liver cirrhosis, along with decreases in PPARa. The 93 endstage livers had much higher inter-individual variations in gene expression than 35 normal livers. CONCLUSION: the expression of CYP enzyme genes and corresponding nuclear receptors was generally decreased in end-stage liver diseases, and significant differences in gene expression were evident between peri-HCC and HCC. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:8681 / 8690
页数:10
相关论文
共 38 条
[1]   CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores [J].
Albarmawi, Albader ;
Czock, David ;
Gauss, Annika ;
Ehehalt, Robert ;
Bermejo, Justo Lorenzo ;
Burhenne, Juergen ;
Ganten, Tom M. ;
Sauer, Peter ;
Haefeli, Walter E. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (01) :160-169
[2]   Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice [J].
Aleksunes, Lauren M. ;
Klaassen, Curtis D. .
DRUG METABOLISM AND DISPOSITION, 2012, 40 (07) :1366-1379
[3]   Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role [J].
Aubert, J. ;
Begriche, K. ;
Knockaert, L. ;
Robin, M. A. ;
Fromenty, B. .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (10) :630-637
[4]   Therapeutic Drug Monitoring of Lacosamide [J].
Bentue-Ferrer, Daniele ;
Tribut, Olivier ;
Verdier, Marie-Clemence .
THERAPIE, 2012, 67 (02) :151-155
[5]   Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver? [J].
Buechler, Christa ;
Weiss, Thomas S. .
CURRENT DRUG METABOLISM, 2011, 12 (01) :24-34
[6]  
Chiu KW, 2010, ANN TRANSPL, V15, P38
[7]   In Vitro Cytochrome P450 Activity Decreases in Children with High Pediatric End-Stage Liver Disease Scores [J].
De Bock, Lies ;
Boussery, Koen ;
Van Winckel, Myriam ;
De Paepe, Peter ;
Rogiers, Xavier ;
Stephenne, Xavier ;
Sokal, Etienne ;
Van Bocxlaer, Jan .
DRUG METABOLISM AND DISPOSITION, 2013, 41 (02) :390-397
[8]   The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes [J].
Elbekai, RH ;
Korashy, HM ;
El-Kadi, AOS .
CURRENT DRUG METABOLISM, 2004, 5 (02) :157-167
[9]   Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease [J].
Fisher, Craig D. ;
Lickteig, Andrew J. ;
Augustine, Lisa M. ;
Ranger-Moore, James ;
Jackson, Jonathan P. ;
Ferguson, Stephen S. ;
Cherrington, Nathan J. .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (10) :2087-2094
[10]  
GEORGE J, 1995, HEPATOLOGY, V21, P120, DOI 10.1016/0270-9139(95)90418-2